Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 100 participants.
Also called NCT03584217
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Phase 1/2
- Enrolled
- 100 participants
- Registry
-
NCT03584217
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03584217. Allocation not applicable; no masking; primary purpose diagnostic. Start 2018-10-01 (actual); primary completion 2023-06-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study
- Acronym
- Renal-HEIR
- Condition
- Type 2 Diabetes Mellitus
- Condition
- Obesity
- Condition
- Nephropathy
- Condition
- Adolescent Obesity
- Intervention (Drug)
- Aminohippurate Sodium Inj 20%
- Intervention (Drug)
- Iohexol Inj 300 MG/ML
- Intervention (Procedure)
- Renal Biopsy
- Lead sponsor
- University of Colorado, Denver
Record details
- Record id
cardio:ct-nct03584217- Content hash
6bff78b9da1fde672b06232640f5f4ff9c111a76a73ce8fdeccccb6293339a36